Acid-sensing ion channel-1a in the amygdala, a novel therapeutic target in depression-related behavior

Matthew W. Coryell, Amanda M. Wunsch, Jill M. Haenfler, Jason E. Allen, Mikael Schnizler, Adam E. Ziemann, Melloni N. Cook, Jonathan P. Dunning, Margaret P. Price, Jon D. Rainier, Zhuqing Liu, Alan R. Light, Douglas R. Langbehn, John A. Wemmie

Research output: Contribution to journalArticlepeer-review

106 Scopus citations

Abstract

No animal models replicate the complexity of human depression. However, a number of behavioral tests in rodents are sensitive to antidepressants and may thus tap important underlying biological factors. Such models may also offer the best opportunity to discover novel treatments. Here, we used several of these models to test the hypothesis that the acid-sensing ion channel-1a (ASIC1a) might be targeted to reduce depression. Genetically disrupting ASIC1a in mice produced antidepressant-like effects in the forced swim test, the tail suspension test, and following unpredictable mild stress. Pharmacologically inhibiting ASIC1a also had antidepressant-like effects in the forced swim test. The effects of ASIC1a disruption in the forced swim test were independent of and additive to those of several commonly used antidepressants. Furthermore, ASIC1a disruption interfered with an important biochemical marker of depression, the ability of stress to reduce BDNF in the hippocampus. Restoring ASIC1a to the amygdala of ASIC1a-/- mice with a viral vector reversed the forced swim test effects, suggesting that the amygdala is a key site of ASIC1a action in depression-related behavior. These data are consistent with clinical studies emphasizing the importance of the amygdala in mood regulation, and suggest that ASIC1a antagonists may effectively combat depression.

Original languageEnglish (US)
Pages (from-to)5381-5388
Number of pages8
JournalJournal of Neuroscience
Volume29
Issue number17
DOIs
StatePublished - Apr 29 2009

Fingerprint Dive into the research topics of 'Acid-sensing ion channel-1a in the amygdala, a novel therapeutic target in depression-related behavior'. Together they form a unique fingerprint.

Cite this